Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
58,643,980
-
Number of holders
-
149
-
Total 13F shares, excl. options
-
27,958,847
-
Shares change
-
+251,410
-
Total reported value, excl. options
-
$2,636,827,051
-
Value change
-
-$36,991,648
-
Put/Call ratio
-
168%
-
Number of buys
-
95
-
Number of sells
-
63
-
Price
-
$94.30
Institutional Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) as of Q1 2015
As of 31 Mar 2015 AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) had 149 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 27,958,847 shares of stock of the company.
Largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, Capital World Investors, Flagship Ventures 2007 General Partner LLC, BB BIOTECH AG, VANGUARD GROUP INC, Capital International Investors, BlackRock Fund Advisors, CAPITAL GUARDIAN TRUST CO, and PRICE T ROWE ASSOCIATES INC /MD/.
This table shows 149 institutional shareholders of the security as of 31 Mar 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.